Study of the Effect of Amlodipine, Atenolol, Enalapril and Losartan in Patients with Mild to Moderate Hypertension
Journal Title: International journal of Emerging Trends in Science and Technology - Year 2015, Vol 2, Issue 8
Abstract
Objectives: To evaluate and compare the efficacy and tolerability of amlodipine, atenolol, enalapril and losartan in patients with mild to moderate hypertension. Research design and method: This study was conducted in medicine department of tertiary care teaching hospital. This was prospective, open labelled, observational, randomized controlled clinical trial. Patients aged 30-60 years, newly diagnosed as mild to moderate hypertension were enrolled in the study. Pretreatmentevaluation of all the patients was done. Detailed clinical history, physical examination and routine laboratory investigations were done. Eligible patients were randomized to receive Amlodipine 2.5/5 mg, Atenolol 25/ 50 mg, Enalapril5/ 10 mg, Losartan 25/50 mg and followed them for 12 weeks, patient’svisits scheduled at 2 weeks interval. Primary efficacy end point was reduction in mean systolic blood pressure (SBP) and mean diastolic blood pressure (DBP). Safety was assessed in terms of systemic adverse events both subjective and objective (clinical and biochemical examinations). Results: Total 154 patients were enrolled, patients’ demographic and baseline clinical characteristics were comparable in all treatment groups. After 12 weeks of treatment the reduction in mean systolic blood pressure were 22.55±7.74, 21±7.94, 20.35±5.48, 22.61±8.41. Reduction in mean diastolic blood pressure were 13.11±4.31, 10.11±3.24, 11.5±3.39, 12.72±3.38. The change in heart rate was 84.22 ± 5.71 to 85.56 ± 5.81, 83.27 ± 5.72 to 69.05 ± 7.68, 84 ± 6.17 to 85.72±5.47, 82.33 ± 7.15 to 83.5±7.54. The change in average serum potassium levels 3.81 ± 0.39 to 3.79 ± 0.36, 3.79 ± 0.33 to 3.69 ± 0.22, 3.72 ± 0.35 to 4.08 ± 0.38, 3.74 ± 0.40 to 3.81 ± 0.27. Adverse events percentage was 38.88 percent, 36.11 percent, 36.11 percent and 13.88 percent in all 4 study group respectively. Conclusion: Amlodipine, Atenolol, Enalapril, and Losartan are equal efficacious to reduce SBP and DBP, whereas losartan is better tolerated and comparatively safer than amlodipine, atenolol and enalapril in patients with mild to moderate hypertension.
Authors and Affiliations
Ujwala P. Gawali
Keywords
Related Articles
- EP ID EP241965
- DOI -
- Views 72
- Downloads 0
Water Quality of Rajgir Hot Spring, Nalanda Bihar
The Rajgir hot spring sites located in Nalanda district of Bihar State. This spring is sulphur containing hot spring. The various parameters analyzed were Temperature, pH, Electrical Conductivity, Total Hardness, Total A...
Homestead plant diversity in the south-central coastal saline region of Bangladesh: utilization and conservation
The present study has found a total of 189 plant species belonging to 152 genera and 74 families growing in homesteads in the south-central coastal region of Bangladesh. Despite variation of species diversity was found i...
A Novel Approach to Implement Local Edge Preserving Filter for High Dynamic Range Image Tone Mapping
Edge detection is mainly used in image processing, and is used for feature selection and feature extraction. Edge preservation is important in filtering design to avoid the halo artifacts. Edge preserving decomposition o...
Efficient iSLIP Arbiter with iSLIP Scheduling Algorithm for NoC
Increasing complexity of the individual devices, the increasing demand for higher bandwidth on the network lines and an operating frequency hitting new limits with almost every new design, place the communication and com...
Optimum Hierarchical Modulations for OFDM Systems and Uplink Virtual MIMO Systems
A fast linear minimum mean sq. error (LMMSE) channel estimation methodology has been planned for Orthogonal Frequency Division Multiplexing (OFDM) systems as compared with the standard LMMSE channel estimation, numerical...